AnaptysBio Inc
NASDAQ:ANAB

Watchlist Manager
AnaptysBio Inc Logo
AnaptysBio Inc
NASDAQ:ANAB
Watchlist
Price: 23.47 USD -2.61% Market Closed
Market Cap: 714.2m USD
Have any thoughts about
AnaptysBio Inc?
Write Note

Balance Sheet

Balance Sheet Decomposition
AnaptysBio Inc

Current Assets 448.7m
Cash & Short-Term Investments 430.1m
Receivables 12.2m
Other Current Assets 6.4m
Non-Current Assets 44.7m
Long-Term Investments 27.9m
PP&E 16.6m
Other Non-Current Assets 256k
Current Liabilities 43.9m
Accounts Payable 3.6m
Accrued Liabilities 40.3m
Non-Current Liabilities 365.2m
Other Non-Current Liabilities 365.2m

Balance Sheet
AnaptysBio Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
22
52
51
81
114
171
251
496
71
36
Cash Equivalents
22
52
51
81
114
171
251
496
71
36
Short-Term Investments
0
0
0
167
314
203
143
52
370
355
Total Receivables
2
1
5
2
0
0
0
1
1
7
Other Current Assets
1
1
2
3
7
4
3
5
5
9
Total Current Assets
24
54
58
253
434
378
397
554
447
407
PP&E Net
1
1
1
1
1
3
2
22
20
18
PP&E Gross
1
1
1
1
1
3
2
22
20
18
Accumulated Depreciation
3
4
4
4
4
5
5
5
6
6
Long-Term Investments
0
0
0
76
73
54
18
67
143
27
Other Long-Term Assets
0
2
4
0
0
0
0
0
0
0
Total Assets
25
N/A
56
+124%
62
+10%
329
+430%
509
+55%
435
-14%
417
-4%
643
+54%
610
-5%
452
-26%
Liabilities
Accounts Payable
0
2
2
2
5
16
4
2
3
5
Accrued Liabilities
1
3
3
5
9
12
16
14
23
33
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
7
8
1
0
0
0
0
Other Current Liabilities
10
3
0
0
0
0
0
0
0
0
Total Current Liabilities
12
7
6
14
22
30
20
16
26
37
Long-Term Debt
5
5
14
8
1
0
0
0
0
0
Other Liabilities
3
2
3
0
0
1
0
271
322
327
Total Liabilities
19
N/A
14
-27%
23
+65%
22
-5%
23
+4%
30
+34%
20
-34%
287
+1 347%
348
+22%
364
+5%
Equity
Common Stock
37
78
78
0
0
0
0
0
0
0
Retained Earnings
45
51
55
85
147
244
264
322
451
614
Additional Paid In Capital
14
16
17
393
633
649
661
679
718
703
Other Equity
0
0
0
0
0
0
0
0
5
1
Total Equity
6
N/A
42
+605%
39
-7%
308
+683%
486
+58%
405
-17%
397
-2%
356
-10%
262
-26%
88
-66%
Total Liabilities & Equity
25
N/A
56
+124%
62
+10%
329
+430%
509
+55%
435
-14%
417
-4%
643
+54%
610
-5%
452
-26%
Shares Outstanding
Common Shares Outstanding
19
19
20
24
27
27
27
28
29
27

See Also

Discover More